Search alternatives:
significance greatest » significance test (Expand Search), significantly greater (Expand Search), significance tests (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
greatest decrease » treatment decreased (Expand Search), greater increase (Expand Search)
significance greatest » significance test (Expand Search), significantly greater (Expand Search), significance tests (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
greatest decrease » treatment decreased (Expand Search), greater increase (Expand Search)
-
1981
-
1982
-
1983
-
1984
ROS, K<sup>+</sup> efflux and cathepsin B are required for NLRP3 activation.
Published 2025Subjects: -
1985
-
1986
-
1987
-
1988
Differences in health-related quality of life indexes after disease onset between groups.
Published 2025Subjects: -
1989
Changes in subcutaneous fat thickness and muscle mass (Approximately here).
Published 2025Subjects: -
1990
-
1991
-
1992
Ba/F3 EML4-ALK<sup>mutants</sup> exhibit variable dose-response to ABT-199 treatment.
Published 2025Subjects: -
1993
-
1994
-
1995
-
1996
-
1997
-
1998
-
1999
-
2000